Atorvastatin decrease GATA4 and MEF2C transcription factors in human cardiac fibroblasts.
About the publication
Record:
CHOMANIČOVÁ, Nikola - ADAMIČKOVÁ, Adriana - VALÁŠKOVÁ, Simona - MOLITORISOVÁ, Miroslava - GAŽOVÁ, Andrea - KYSELOVIČ, Ján. Atorvastatin decrease GATA4 and MEF2C transcription factors in human cardiac fibroblasts. In: Česko-slovenské farmakologické dni. European Pharmaceutical Journal : Acta Facultatis Pharmaceuticae Universitatis Comenianae. 2022. ISSN 2453-6725, Vol. 69, suppl. 1 (2022), p. 43.
Year:
2022
Category:
V3 - Scientific output of publication activity from the journal
Output type:
ABP - abstract from the event
Authors:
CHOMANIČOVÁ Nikola
0 %
ADAMIČKOVÁ Adriana
0 %
VALÁŠKOVÁ Simona
0 %
MOLITORISOVÁ Miroslava
0 %
GAŽOVÁ Andrea
0 %
0 %
UVMP share:
0 %
Edition:
European Pharmaceutical Journal
Acta Facultatis Pharmaceuticae Universitatis Comenianae
Vol. 69, suppl. 1 (2022), p. 43
Country of issue:
Slovakia
ISSN:
2453-6725
Research area:
180 - Medical, pharmaceutical and non-medical health sciences
Field:
Group of study fields: Health sciences and fields aimed at improving the quality of life
Name of the field of study: pharmacy
Scientometrics:
8 - H-index, 0.138 - SJR, Q4 - SJR Best Q
Language:
english